Complete Response to Temozolomide in Metastatic Melanoma After Failure of 5 Lines of Treatment

被引：4
|
作者：
Magge, Tara [1 ]
Shaikh, Hira [2 ]
Chaudhary, Rekha [2 ]
机构：
[1] Univ Cincinnati, Dept Internal Med, Cincinnati, OH 45221 USA
[2] Univ Cincinnati, Dept Hematol & Oncol, Cincinnati, OH USA
来源：
AMERICAN JOURNAL OF THERAPEUTICS | 2022年 / 29卷 / 06期
关键词：
PHASE-III; CHEMOTHERAPY; SURVIVAL; INHIBITORS; NIVOLUMAB; RATES;
D O I：
10.1097/MJT.0000000000001186
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
引用
收藏
页码：E767 / E769
页数：3
相关论文
共 50 条
  • [21] Complete response to immunotherapy in a nonagenarian patient with metastatic melanoma
    Foo, Tiffany
    Rico, Gonzalo Tapia
    Brown, Michael P.
    BMJ CASE REPORTS, 2020, 13 (07)
  • [22] Phase II study of temozolomide plus thalidomide for the treatment of metastatic melanoma
    Hwu, WJ
    Krown, SE
    Menell, JH
    Panageas, KS
    Merrell, J
    Lamb, LA
    Williams, LJ
    Quinn, CJ
    Foster, T
    Chapman, PB
    Livingston, PO
    Wolchok, JD
    Houghton, AN
    JOURNAL OF CLINICAL ONCOLOGY, 2003, 21 (17) : 3351 - 3356
  • [23] PARP1 variants associated with response to Temozolomide in metastatic melanoma patients
    Sedgewick, A.
    Romkes, M.
    Buch, S.
    Villaruz, L.
    Abecassis, I.
    Saul, M.
    Kirkwood, J. M.
    Benos, P. V.
    Tawbi, H.
    EUROPEAN JOURNAL OF CANCER, 2013, 49 : S33 - S34
  • [24] Outcomes of patients with unresectable or metastatic melanoma after cessation of immunotherapy following complete response or toxicities
    Zulkifli, N. S.
    Tam, L.
    Mclean, A.
    Atkinson, V. G.
    ANNALS OF ONCOLOGY, 2023, 34 : S668 - S668
  • [25] Late-Onset Paraplegia after Complete Response to Two Cycles of lpilimumab for Metastatic Melanoma
    O'Kane, Grainne M.
    Lyons, Tomas G.
    Colleran, Gabrielle C.
    Ahmad, Marzuki Wan
    Alken, Scheryll
    Kavanagh, Eoin C.
    Fitzpatrick, David
    Murray, Brian
    Kelly, Catherine M.
    ONCOLOGY RESEARCH AND TREATMENT, 2014, 37 (12) : 757 - 760
  • [26] MPC-6827 is safely combined with temozolomide for the treatment of patients with metastatic melanoma
    Hamid, Omid
    Akerley, Wallace
    Stephenson, Joseph
    Yu, Margaret K.
    Evans, Brent A.
    Mather, Gary
    Swabb, Edward A.
    Hwu, Wen-Jen
    MOLECULAR CANCER THERAPEUTICS, 2009, 8 (12)
  • [27] Alternative temozolomide dosing regimens and novel combinations for the treatment of advanced metastatic melanoma
    Hwu, Wen-Jen
    Ayala, Ana E.
    Hernandez, Ingrid M.
    ONCOLOGY REVIEWS, 2008, 2 (03) : 183 - 193
  • [28] Temozolomide and cisplatin in the treatment of leptomeningeal metastatic involvement from melanoma: a case report
    A. Salmaggi
    A. Silvani
    M. Eoli
    E. Lamperti
    A. Boiardi
    Neurological Sciences, 2002, 23 : 257 - 258
  • [29] Response of Extracranial Lesions After Treatment of Metastatic Melanoma With Cranial Radiation and Ipilimumab
    Schoenfeld, J. D.
    Mahadevan, A.
    Floyd, S. R.
    Dyer, M. A.
    Catalano, P.
    Alexander, B. M.
    McDermott, D.
    Kaplan, I. D.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2014, 90 : S775 - S775
  • [30] A Systemic Complete Response of Metastatic Melanoma to Local Radiation and Immunotherapy
    Hiniker, Susan M.
    Chen, Daniel S.
    Reddy, Sunil
    Chang, Daniel T.
    Jones, Jennifer C.
    Mollick, Joseph A.
    Swetter, Susan M.
    Knox, Susan J.
    TRANSLATIONAL ONCOLOGY, 2012, 5 (06) : 404 - 407
12345